BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 26279144)

  • 1. p27(Kip1) signaling: Transcriptional and post-translational regulation.
    Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
    Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
    Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI
    Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage-specific DNA binding protein 1 (DDB1) is involved in ubiquitin-mediated proteolysis of p27Kip1 in response to UV irradiation.
    Iovine B; Iannella ML; Bevilacqua MA
    Biochimie; 2011 May; 93(5):867-75. PubMed ID: 21237244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.
    Hattori T; Isobe T; Abe K; Kikuchi H; Kitagawa K; Oda T; Uchida C; Kitagawa M
    Cancer Res; 2007 Nov; 67(22):10789-95. PubMed ID: 18006823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation.
    Borriello A; Naviglio S; Bencivenga D; Caldarelli I; Tramontano A; Speranza MC; Stampone E; Sapio L; Negri A; Oliva A; Sinisi AA; Spina A; Della Ragione F
    Oxid Med Cell Longev; 2016; 2016():2481865. PubMed ID: 26682002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors.
    Miranda-Carboni GA; Krum SA; Yee K; Nava M; Deng QE; Pervin S; Collado-Hidalgo A; Galic Z; Zack JA; Nakayama K; Nakayama KI; Lane TF
    Genes Dev; 2008 Nov; 22(22):3121-34. PubMed ID: 19056892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression.
    O'Hagan RC; Ohh M; David G; de Alboran IM; Alt FW; Kaelin WG; DePinho RA
    Genes Dev; 2000 Sep; 14(17):2185-91. PubMed ID: 10970882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1.
    Jonason JH; Gavrilova N; Wu M; Zhang H; Sun H
    Cell Cycle; 2007 Apr; 6(8):951-61. PubMed ID: 17438373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
    Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
    Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.